A metagenomic study identifies a Prevotella copri enriched microbial profile associated with non-alcoholic steatohepatitis in subjects with obesityOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
Researchers characterized the gut metagenome in 45 patients with obesity and biopsy-proven non-alcoholic fatty liver disease (NAFLD). Groups included 11 non-NAFL controls, 11 with fatty liver, and 23 with non-alcoholic steatohepatitis (NASH).
How was it studied?
Gut microbiome composition was evaluated using shotgun metagenomic sequencing. Hierarchical clustering grouped subjects by microbial profile, and functional pathway analyses assessed LPS biosynthesis and butyrate production capacity.
What did they find?
Parabacteroides distasonis and Alistipes putredenis were enriched in fatty liver but not NASH. Membership in a Prevotella copri dominant cluster tracked with greater NASH risk, and this cluster showed higher circulating LPS and fewer butyrate production pathways, despite similar LPS biosynthesis genes.
Why it matters
A Prevotella copri dominant gut community may signal greater risk for NAFLD progression to NASH. The authors link this to higher intestinal permeability and reduced butyrate producing capacity.